[
  {
    "masterId": "NCLEX-2026-MISSION-500-8-1771956732625",
    "itemType": "standalone",
    "category": "chartExhibit",
    "topic": "Heparin/Warfarin Anticoagulation Safety",
    "mission": "Generate ONE Elite-Level Standalone NGN Item.",
    "specifications": [
      "TAB SYNC: Populated EHR subsections in 'itemContext' (SBAR, Labs, Vitals, Radiology, MAR) MUST sync with the item stem.",
      "SBAR: Exactly 120-160 words, military time (HH:mm), SBAR format.",
      "SCORING RULES: SATA/Highlight: Polytomous (+/- 1.0 penalty); Matrix/Cloze: 0/1 (no penalty); Bowtie: Linked Dyad/Triad scoring.",
      "RATIONALE: Deep clinical/pathophysiological explanations. No 'Opt X is wrong' generic filler.",
      "EXTRAS: Mandatory 'clinicalPearls', 'questionTrap' (strategy), and 'mnemonic'."
    ],
    "itemContext": {
      "SBAR": "14:00 Report for Ms. Eleanor Vance, a 78-year-old female admitted for atrial fibrillation. Situation: Ms. Vance’s INR is critically high at 6.8. Background: She has been on warfarin 5mg daily for the past six months due to persistent atrial fibrillation. She denies any recent changes in diet or medication. Assessment: Ms. Vance is alert and oriented, but reports recent episodes of epistaxis and easy bruising. Her vital signs are stable: BP 130/80 mmHg, HR 88 bpm, RR 18, SpO2 98% on room air.  She is currently not actively bleeding, but the elevated INR poses a significant risk. Recommendation: I recommend immediate discontinuation of warfarin, administration of Vitamin K, and close monitoring for signs of bleeding. A repeat INR should be drawn in 4 hours to assess the response to Vitamin K.",
      "Labs": {
        "INR": "6.8",
        "PT": "70 seconds",
        "PTT": "35 seconds",
        "Hemoglobin": "11.5 g/dL",
        "Platelets": "200,000/mcL"
      },
      "Vitals": {
        "BP": "130/80 mmHg",
        "HR": "88 bpm",
        "RR": "18",
        "SpO2": "98%"
      },
      "Radiology": "No recent radiology reports available.",
      "MAR": [
        "Warfarin 5mg PO daily",
        "Acetaminophen 500mg PO PRN for pain",
        "Docusate 100mg PO daily"
      ]
    },
    "stem": "Ms. Eleanor Vance, a 78-year-old patient on warfarin for atrial fibrillation, presents with a critically elevated INR of 6.8. Based on the provided information, complete the following actions in the order they should be performed.",
    "taskModel": {
      "modelType": "bowtie",
      "premise": "Indications of the Problem",
      "action1": "Action 1",
      "action2": "Action 2",
      "potentialOutcomes": "Potential Desired Outcomes",
      "optionsPremise": [
        "Elevated INR",
        "Atrial Fibrillation",
        "Epistaxis",
        "Stable Vital Signs",
        "Patient taking Warfarin 5mg daily"
      ],
      "optionsAction1": [
        "Administer Protamine Sulfate",
        "Hold Warfarin",
        "Administer Vitamin K",
        "Administer Fresh Frozen Plasma (FFP)",
        "Initiate Continuous Heparin Infusion"
      ],
      "optionsAction2": [
        "Monitor for signs of bleeding",
        "Encourage ambulation",
        "Educate on high-fiber diet",
        "Apply pressure to epistaxis site",
        "Prepare for blood transfusion"
      ],
      "optionsOutcomes": [
        "INR within therapeutic range (2-3)",
        "Cessation of bleeding",
        "Resolution of atrial fibrillation",
        "Prevention of thromboembolic events",
        "Improved patient comfort"
      ],
      "responsePremise": [
        "Elevated INR",
        "Epistaxis"
      ],
      "responseAction1": [
        "Hold Warfarin",
        "Administer Vitamin K"
      ],
      "responseAction2": [
        "Apply pressure to epistaxis site",
        "Monitor for signs of bleeding"
      ],
      "responseOutcomes": [
        "INR within therapeutic range (2-3)",
        "Cessation of bleeding",
        "Prevention of thromboembolic events"
      ]
    },
    "rationale": {
      "premise": {
        "Elevated INR": "An elevated INR (International Normalized Ratio) indicates that the patient's blood is taking too long to clot, significantly increasing the risk of bleeding. An INR of 6.8 is critically high and requires immediate intervention to reduce the risk of spontaneous hemorrhage. This is directly linked to the warfarin therapy and necessitates an immediate change in the treatment plan.",
        "Epistaxis": "Epistaxis (nosebleeds) in a patient on warfarin with an elevated INR is a clinical manifestation of excessive anticoagulation. This symptom confirms the risk of bleeding and warrants immediate attention to reverse the effects of warfarin and prevent further bleeding complications."
      },
      "action1": {
        "Hold Warfarin": "With a critically elevated INR of 6.8, the first priority is to immediately hold the warfarin to prevent further prolongation of clotting time and reduce the risk of bleeding. Continuing warfarin would exacerbate the patient's condition and could lead to serious or life-threatening hemorrhage.",
        "Administer Vitamin K": "Vitamin K is the antidote for warfarin. It helps the liver produce clotting factors, thereby reversing the effects of warfarin and reducing the INR. Administering Vitamin K will help bring the INR back into a safer range, mitigating the risk of bleeding. The dosage and route of administration (oral or IV) will depend on the severity of the INR elevation and the patient's clinical condition."
      },
      "action2": {
        "Apply pressure to epistaxis site": "Applying direct pressure to the site of epistaxis is a crucial immediate intervention to stop the bleeding. This action helps to physically control the bleeding while the effects of Vitamin K begin to take effect. Pressure should be applied continuously for at least 10-15 minutes.",
        "Monitor for signs of bleeding": "Continuous monitoring for signs of bleeding, such as hematuria, melena, bruising, and changes in mental status, is essential to detect any further bleeding complications early. This allows for prompt intervention and prevents further deterioration of the patient's condition. Frequent vital sign checks are also important to assess for hypovolemia secondary to blood loss."
      },
      "outcomes": {
        "INR within therapeutic range (2-3)": "The desired outcome of interventions is to bring the patient's INR back within the therapeutic range (typically 2-3 for atrial fibrillation). This indicates that the anticoagulation is appropriately managed, reducing the risk of both bleeding and thromboembolic events. Regular INR monitoring is necessary to ensure the patient remains within this range.",
        "Cessation of bleeding": "Stopping the active bleeding is a critical outcome. Controlling the epistaxis and preventing further bleeding is essential for patient safety and comfort. Successful management includes both immediate interventions to stop the bleeding and subsequent measures to correct the underlying cause of the bleeding (i.e., elevated INR).",
        "Prevention of thromboembolic events": "While addressing the immediate risk of bleeding, it is also important to prevent thromboembolic events that warfarin is intended to prevent in the first place. Achieving a therapeutic INR prevents both bleeding and clotting complications. Once the INR is within range, the patient can be safely restarted on anticoagulation therapy if necessary, while carefully monitoring the INR and adjusting the dose as needed."
      },
      "correct": "Clinical rationale pending deep clinical alignment."
    },
    "clinicalPearls": "In patients on warfarin with significantly elevated INRs and active bleeding, a combination of Vitamin K and prothrombin complex concentrate (PCC) may be necessary for faster reversal of anticoagulation. Close monitoring of the patient's clinical condition and frequent INR checks are crucial in guiding treatment decisions.",
    "questionTrap": "A common mistake is to only focus on lowering the INR without addressing the active bleeding. Another trap is administering protamine sulfate which reverses heparin, not warfarin. Prioritizing 'monitoring' before active interventions is also a common error.",
    "mnemonic": "When INR is 'Way Too High' (6.8), 'Hold' the Warfarin and give Vitamin K 'Right Away' to prevent 'Bleeding All Day'.",
    "references": [
      "van Heerde, W. L., van Gorp, R. H., & Hamulyák, K. (2012). Vitamin K antagonists: indication, management, and complications during perioperative dental care. *Journal of Thrombosis and Haemostasis*, *10*(4), 539-546.",
      "Holbrook, A., Schulman, S., Witt, D. M., Vandvik, P. O., Fish, J., Forgie, M., ... & Guyatt, G. (2012). Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. *Chest*, *141*(2 Suppl), e152S-e194S."
    ],
    "type": "standalone",
    "scoring": {
      "method": "polytomous",
      "maxPoints": 1
    },
    "pedagogy": {
      "bloomLevel": "apply",
      "cjmmStep": "analyzeCues",
      "nclexCategory": "Physiological Adaptation",
      "topicTags": [
        "Uncategorized"
      ],
      "difficulty": 4
    }
  }
]